Evaluation of severe hypoglycemia and common mental disorders in patients receiving insulin analogues for treatment of type 1 diabetes

AUTOR(ES)

Berlanda, Gabriela; Telo, Gabriela H.; Krug, Barbara Côrrea; Scheffel, Rafael Selbach; Pasinato, Bruna; Iorra, Fernando; Reis, João Gabbardo dos; Picon, Paulo Dornelles; Schaan, Beatriz D.

FONTE

Arch. Endocrinol. Metab.

DATA DE PUBLICAÇÃO

2021-02

RESUMO

ABSTRACT This is a retrospective report of the frequency of severe hypoglycemia and the association between common mental disorders and type 1 diabetes mellitus treated with insulin analogues. Patients with severe hypoglycemia compared with those without this complication had a higher prevalence of positive screening for common mental disorders (88% vs.77%, respectively, p = 0.03).

Documentos Relacionados

• Hypoglycemia frequency and treatment satisfaction in patients receiving insulin analogues for treatment of type 1 diabetes mellitus
• A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers: Applicability of a novel insulin-independent treatment
• Insulin analogues versus human insulin in type 1 diabetes: direct and indirect meta-analyses of efficacy and safety
• Hypoglycemia in type 1 diabetes: a burden to worry about during treatment
• Effects of Acute Insulin-Induced Hypoglycemia on Spatial Abilities in Adults With Type 1 Diabetes